MDVN

Medivation, Inc. News Headlines

$102.26
*  
1.33
1.32%
Get MDVN Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading MDVN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Alnylam (ALNY) to File Clinical Trial Application for ALN-CC5 - Analyst Blog
9/18/2014 5:10:00 PM - Zacks.com

Analysts' Actions: Kohl's, Medivation, Owens-Illinois, Pier 1
9/18/2014 8:23:00 AM - TheStreet

Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog
9/17/2014 3:00:00 PM - Zacks.com

Is There Further Upside In Medivation?
9/16/2014 8:27:00 AM - Seeking Alpha

Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog
9/15/2014 7:00:00 PM - Zacks.com

Zacks Rank #1 Additions for Monday - Tale of the Tape
9/15/2014 9:30:00 AM - Zacks.com

Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious
9/15/2014 8:41:00 AM - Seeking Alpha

Medivation, Now The Deluge
9/12/2014 7:44:00 AM - Seeking Alpha

Medivation-Astellas' Xtandi's Label Expanded by FDA - Analyst Blog
9/11/2014 6:35:00 PM - Zacks.com

Medivation Eyes Blockbuster As Cancer Drug Gets An OK
9/11/2014 5:41:00 PM - Investor's Business Daily

Medivation Inc's FDA Approval Could be the Deathblow for Johnson & Johnson's Blockbuster Prostate Ca
9/10/2014 9:42:22 PM - Motley Fool

Medivation To Present At Morgan Stanley Conference; Webcast At 9:20 AM ET
9/8/2014 8:22:00 AM - RTT News

Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte
9/5/2014 8:55:00 AM - TheStreet

Merck Collaboration Could Add $150M To Advaxis' Present Value
8/26/2014 11:02:00 AM - Seeking Alpha

Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog
8/19/2014 5:25:00 PM - Zacks.com

Medivation Jumps on Q2 Earnings Beat, Outlook Encourages - Analyst Blog
8/11/2014 12:10:00 PM - Zacks.com

Medivation (MDVN) Jumps: Stock Adds 7.5% in Session - Tale of the Tape
8/11/2014 8:51:00 AM - Zacks.com

Medivation Results Surpass Estimate On Xtandi Sales; Lifts Guidance; Stock Up 4%
8/7/2014 7:29:00 PM - RTT News

After-Hours Earnings Report for August 7, 2014 : CBS, ED, BAP, MNST, NVDA, CSC, CFN, SLXP, FRT, SCTY, NWSA, MDVN
8/7/2014 2:00:02 PM - NASDAQ.com News

One Drug To Rule Them All: Medivation's Xtandi To Dominate Prostate Cancer Market
8/5/2014 9:33:00 AM - Seeking Alpha

One Drug To Rule Them All: Medivation's Xtandi To Dominate Prostate Cancer Market
8/5/2014 8:51:23 AM - SeekingAlpha

One Drug To Rule Them All: Medivation's Xtandi To Dominate Prostate Cancer Market
8/5/2014 8:51:00 AM - Seeking Alpha

A Quick Look At 2 Small-Cap Bio-Pharmaceutical Companies: Discovery Labs And Exelexis
8/1/2014 9:22:00 PM - Seeking Alpha

First Week of MDVN March 2015 Options Trading
7/22/2014 12:18:39 PM - BNK Invest

Astellas Up on Pipeline Update, Oncology in Focus (revised) - Analyst Blog
7/21/2014 4:07:46 PM - Zacks.com